RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 87 filers reported holding RELMADA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,994 | -90.2% | 12,998 | -92.0% | 0.00% | – |
| Q2 2023 | $399,374 | -11.6% | 162,347 | -18.8% | 0.00% | – |
| Q1 2023 | $451,602 | -50.6% | 199,824 | -23.6% | 0.00% | – |
| Q4 2022 | $913,365 | -65.4% | 261,709 | +266.8% | 0.00% | -100.0% |
| Q3 2022 | $2,641,000 | -24.5% | 71,347 | -61.3% | 0.00% | 0.0% |
| Q2 2022 | $3,498,000 | +342.2% | 184,174 | +528.8% | 0.00% | – |
| Q1 2022 | $791,000 | -58.3% | 29,291 | -65.2% | 0.00% | – |
| Q4 2021 | $1,899,000 | -15.9% | 84,288 | -2.1% | 0.00% | – |
| Q3 2021 | $2,257,000 | +252.1% | 86,082 | +329.4% | 0.00% | – |
| Q2 2021 | $641,000 | -21.8% | 20,045 | -13.9% | 0.00% | – |
| Q1 2021 | $820,000 | +81.4% | 23,284 | +65.3% | 0.00% | – |
| Q4 2020 | $452,000 | -87.5% | 14,085 | -86.7% | 0.00% | -100.0% |
| Q1 2020 | $3,624,000 | +1617.5% | 106,245 | +1862.8% | 0.00% | – |
| Q4 2019 | $211,000 | – | 5,413 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Guild Investment Management, Inc. | 205,300 | $615,900 | 1.03% |
| Deep Track Capital, LP | 2,837,818 | $8,513,454 | 0.33% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 974,082 | $2,922,246 | 0.23% |
| apricus wealth, LLC | 77,362 | $239,822 | 0.21% |
| Palo Alto Investors LP | 732,400 | $2,197,200 | 0.21% |
| RTW INVESTMENTS, LP | 2,131,835 | $6,395,505 | 0.14% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 100,000 | $300,000 | 0.09% |
| AdvisorShares Investments LLC | 112,908 | $338,724 | 0.09% |
| Savior LLC | 3,500 | $10,500 | 0.07% |
| Spotlight Asset Group, Inc. | 20,000 | $60,000 | 0.05% |